RICHARD D. RUPPERT, M.D.; NORTON J. GREENBERGER, M.D.; FLOYD M. BEMAN, M.D.; FRANK M. MCCULLOUGH, M.D.
This content is PDF only. Please click on the PDF icon to access.
Eleven years have elapsed since Zollinger and Ellison (1) reported the association of peptic ulcer disease and tumors of the pancreas. To date, over 400 cases have been reported. However, it is not generally appreciated that four of the commonly used tests of gastric acid secretion may not suggest the correct diagnosis. Normal values have been reported for basal acid secretion, histamine-stimulated acid secretion, the ratio of basal/stimulated acid secretion, and 12-hr overnight acid secretion in patients with ulcerogenic tumor of the pancreas (2, 3). We have studied gastric secretion in five patients with Zollinger-Ellison syndrome and in 300 other
RUPPERT RD, GREENBERGER NJ, BEMAN FM, et al. Gastric Secretion in Ulcerogenic Tumors of the Pancreas. Ann Intern Med. 1967;67:808–815. doi: https://doi.org/10.7326/0003-4819-67-4-808
Download citation file:
Published: Ann Intern Med. 1967;67(4):808-815.
Gastroenterology/Hepatology, Hematology/Oncology, Pancreatic Disease.
Results provided by:
Copyright © 2019 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use